Skip to content

Clinical trials

Completed Phase 2 Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Phase 2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20041
20063
20081
20101
20121
20132
20152
20161
20171
20181
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Alliance for Clinical Trials in Oncology2
National Cancer Institute (NCI)2
Northwestern University2
Case Comprehensive Cancer Center1
Dana-Farber Cancer Institute1
European Institute of Oncology1
Fox Chase Cancer Center1
Fred Hutchinson Cancer Center1
Gary Morrow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ22
Breast Neoplasms18
Carcinoma, Intraductal, Noninfiltrating17
Breast Neoplasms, Male1
Carcinoma, Ductal, Breast1
Carcinoma, Lobular1
Hot Flashes1
Paget's Disease, Mammary1
Pain1
Radiodermatitis1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.